California Cancer Reporting System Standards Volume I: Abstracting and Coding Procedures for Hospitals
Laboratory tests and tumor markers recorded in CSv2 site specific factor fields must be documented in the laboratory text field by using the actual name of the test. Do not use "SSF 1-25" to identify the test. Documentation includes date, test type, value, and interpretation (elevated, borderline or normal).
Enter dates, names, and results of laboratory tests or procedures used in establishing the diagnoses of neoplasms or metastases, such as serum protein electrophoresis for multiple myeloma or Waldenstrom's macroglobulinemia, serum alpha fetoprotein (AFP) for liver cancer, and other tumor marker studies.
Record T-and B-cell marker studies on leukemias and lymphomas, but enter hematology reports for leukemia and myeloma under Pathology.
In leukemia cases where both bone marrow and chromosomes are analyzed, the bone marrow results take precedence in coding histologic type, unless more specific information is given in the cytogenetic report. See Section IV.2.
Subcategories of acute myeloid leukemia are described according to cytogenetic abnormalities. If these abnormalities are included in a laboratory report, they take precedence in coding histologic type.
The chromosome study or cytogentic and molecular biological data results can be recorded here. Enter "none" if no pertinent laboratory tests were performed.
Document the date, test type, value and interpretation (elevated, borderline or normal) of any pertinent tumor markers or lab tests in the lab text field.